Jagsonpal Pharmaceuticals has entered into a Business Transfer Agreement (BTA) with Group Pharmaceuticals (Seller) on 23 September 2026, for acquisition of the Wellness Portfolio of the Seller, on a going-concern basis by way of slump sale, subject to the terms and conditions contained in the BTA.
Jagsonpal Pharmaceuticals to acquire wellness portfolio of Group Pharmaceuticals
Jagsonpal Pharmaceuticals has entered into a Business Transfer Agreement (BTA) with Group Pharmaceuticals (Seller) on 23...
By Dhallo News · September 23, 2026 at 7:16 PM IST

Source: Business Standard - Politics
SOURCE: Business Standard - Politics
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion
